Results 91 to 100 of about 5,973 (205)

β-Blocking Properties of Propafenone in Extensive Oxidisers: A Study on Heart Rate Behaviour during Holter Monitoring

, 1993
The aims of this study were to evaluate whether the beta-blocking effect during propafenone treatment is clinically significant even in extensive metabolisers of debrisoquine (> 90% of Caucasians), and to identify the kinetic determinants of such an ...
Capucci, Alessandro, Santarelli, Andrea, Marchesini, Bruno, Magnani, Bruno, Boriani, Giuseppe, Strocchi, Enrico, Biffi, Mauro   +6 more
core   +1 more source

Ventricular Tachycardia Induced by Propafenone Intoxication in a Pediatric Patient

, 2019
Unintentional poisonings are a global health problem frequently resulting in hospital admissions. Propafenone is a class 1C antiarrhythmic drug used in the second-line management of supraventricular and ventricular arrhythmias and, when unintentionally ...
Marzuillo P., Tipo V., Pappacoda S., D'Anna C., Ponticiello E., Rosa M., Di Mita O.   +6 more
core   +1 more source

A Case of Propafenone Toxicity in the Setting of Dehydration and Acute Kidney Injury [PDF]

Propafenone is a class 1C antiarrhythmic and is one of the first-line drugs used in the management of atrial fibrillation. Its toxicity is rare, yet potentially life-threatening.
Haddad, Enad, Collins, Matthew
core   +1 more source

Structure-activity relationships of propafenone analogues on Pseudomonas aeruginosa: experimental and docking studies [PDF]

, 2016
Series of six propafenone analogues has been evaluated for antimicrobial activities against Pseudomonas aeruginosa. Antimicrobial activity were confirmed for all tested compounds. The Docking studies of propafenone analogues into a
Senćanski, Milan V., Božić, D., Grubišić, S., Milenković, Milica, Vujić, Z., Ivković, B.   +5 more
core   +1 more source

Antiarrhythmic therapy effects on quality of life among patients with extrasystoles

Российский кардиологический журнал, 2008
To investigate antiarrhythmic therapy effectiveness, safety and impact on quality of life (QoL) among patients with symptomatic extrasystolia, a study was performed in 152 individuals, with 140 completing the study. Mean age of the patients was 57 years;
V. L. Doshchitsyn, O. A. Kramynina, E. V. Chernova, O. B. Karpunichev, O. V. Barysheva, E. Yu. Shatykhina, Yu. V. Bezborodova   +6 more
doaj  

Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background This study investigated drug–drug interactions in patients with atrial fibrillation taking both a direct oral anticoagulant (DOAC) and an antiarrhythmic drug.
Victor Chien‐Chia Wu, Chun‐Li Wang, Yu‐Chang Huang, Hui‐Tzu Tu, Yu‐Tung Huang, Chang‐Fu Kuo, Shao‐Wei Chen, Kuo‐Chun Hung, Ming‐Shien Wen, Shang‐Hung Chang   +9 more
doaj   +1 more source

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation

Кардиоваскулярная терапия и профилактика, 2006
Aim. To study the effects of three-month propafenone antiarrhythmic therapy (daily dose 450 mg) on inotropic myocardial function in patients with recurrent atrial fibrillation (AF). Material and methods.
I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzhsky   +2 more
doaj  

Ensanchamiento del complejo QRS: ¿hiperkalemia? ¿propafenona?

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2012
RESUMEN La hiperkalemia y la propafenona  son condiciones que enlentecen la velocidad de conducción intracardiaca. Se presenta  una paciente que en el curso de una hiperkalemia moderada y con dosis bajas de propafenona mostró una taquicardia sinusal con
Marleny Cruz Cardentey, Margarita Dorantes Sánchez, Annerys Méndez Rosabal   +2 more
doaj  

Choosing a class IC antiarrhythmic drug for the treatment of patients without structural heart disease: clinical advantages of the most common agents (literature review)

Сучасні медичні технології
Aim: to analyze the pharmacological features and updated evidence-based medicine data of Class IC antiarrhythmic drug (AAD) ethacizine compared to propafenone to optimize the choice of treatment for cardiac arrhythmias in patients without structural ...
N. M. Sydorova, M. Yu. Kolesnyk
doaj   +1 more source

Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial

, 2008
We studied the efficacy of propafenone in preventing atrial tachyarrhythmias after cardiac surgery, and the possible relationships between CYP2D6 polymorphism and the efficacy, pharmacokinetics, and tolerability of propafenone.
Kivisto, K., Hofmann, U., Jagle, C., Igel, S., Wagner, F., Meisner, C., Delabar, U., Bohm, J., Ziemer, G., Schaeffeler, E., Engel, C., Hellberg, K., Drescher, S., Fux, R., Rein, J., Marx, C., Eichelbaum, M., Morike, K., Gleiter, C., Bail, D., et al.   +20 more
core   +1 more source